載入...
Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial
To explore the activity and safety of two schedules of ixabepilone, as first line chemotherapy, in patients with metastatic breast cancer previously treated with adjuvant chemotherapy, a randomized non-comparative phase II study was conducted. From November 2008 until December 2010, 64 patients were...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3720651/ https://ncbi.nlm.nih.gov/pubmed/23935969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0069256 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|